These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8524693)

  • 1. [How to prevent diabetic nephropathy or to delay its development].
    Grzeszczak W
    Pol Arch Med Wewn; 1995 Jul; 94(1):1-7. PubMed ID: 8524693
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there sustained renal benefit from previous intensive insulin therapy in people with type 1 diabetes?
    Shumak SL
    CMAJ; 2004 Jan; 170(1):40-1. PubMed ID: 14707216
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent progress in the treatment of diabetic nephropathy: importance of strict glycemic control on the regression of diabetic nephropathy.
    Kawamori R; Kamado K; Kamada T
    J Diabet Complications; 1991; 5(2-3):88-90. PubMed ID: 1770063
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
    Andersen S; Tarnow L; Cambien F; Rossing P; Juhl TR; Deinum J; Parving HH
    Diabetes Care; 2003 May; 26(5):1501-6. PubMed ID: 12716812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of nephropathy and lipid disorders. Making progress while heeding Molière's warning.
    Bloomgarden ZT
    Diabetes Care; 1994 Aug; 17(8):946-8. PubMed ID: 7956651
    [No Abstract]   [Full Text] [Related]  

  • 6. Current therapeutic management of diabetic nephropathy.
    Kohler SM; Krämer BK
    Acta Diabetol; 1994 Sep; 31(3):119-25. PubMed ID: 7827347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCCT: implications for diabetes care in the UK.
    Boulton AJ
    Diabet Med; 1993 Oct; 10(8):687. PubMed ID: 8261748
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing or postponing renal disease in insulin-dependent diabetes by glycemic and nonglycemic intervention.
    Mogensen CE; Hansen KW
    Contrib Nephrol; 1990; 78():73-100; discussion 100-1. PubMed ID: 2225845
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of renal damage and of risk markers for renal damage in a cohort of diabetic outpatients.
    Catalano C; Bordin V; Panebianco G; Lambertini D; Fabbian F; Di Landro D
    Nephrol Dial Transplant; 1999 Jan; 14(1):248. PubMed ID: 10052529
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical record. Diabetic nephropathy].
    Rev Prat; 2003 Nov; 53(18):2050. PubMed ID: 15008220
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2002 May; 287(19):2563-9. PubMed ID: 12020338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes and HbA1c targets.
    Prescrire Int; 2008 Dec; 17(98):254. PubMed ID: 19425272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3: Preventing complications of diabetes.
    Bate KL; Jerums G
    Med J Aust; 2003 Nov; 179(9):498-503. PubMed ID: 14583083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a random urinary albumin concentration a useful screening test in insulin-treated diabetic patients?
    Beatty OL; Ritchie CM; Hadden DR; Kennedy L; Bell PM; Atkinson AB
    Ir J Med Sci; 1994 Sep; 163(9):406-9. PubMed ID: 7982765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of development and progression of long-term complications in type I diabetes].
    Araki E; Matsumura T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():134-9. PubMed ID: 12386984
    [No Abstract]   [Full Text] [Related]  

  • 18. Early diabetic complications in a population of young patients with type 1 diabetes mellitus despite intensive treatment.
    Nordwall M; Hyllienmark L; Ludvigsson J
    J Pediatr Endocrinol Metab; 2006 Jan; 19(1):45-54. PubMed ID: 16509528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective review of care and outcomes in young adults with type 1 diabetes.
    Wills CJ; Scott A; Swift PG; Davies MJ; Mackie AD; Mansell P
    BMJ; 2003 Aug; 327(7409):260-1. PubMed ID: 12896937
    [No Abstract]   [Full Text] [Related]  

  • 20. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.